Opinion|Videos|December 6, 2024
BRIDGET Trial: Strategies in Maintenance Therapy for HER2+ Breast Cancer with Brain Metastases
Panelists discuss the progress of the BRIDGET trial and its potential impact on HER2-positive breast cancer patients, focusing on the anticipated data and its implications for treatment strategies in this population.
Advertisement
Episodes in this series
Dr Iyengar: Briefly discuss the BRIDGET trial's progress and the potential impact of its anticipated data on HER2-positive breast cancer patients?
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
A Look Back on the Top 10 Oncology Interviews in 2025
2
Spotlighting the Top 10 FDA Oncology Approvals in 2025
3
Zovegalisib Combo Confers Efficacy Benefit in PIK3CA-Mutated Breast Cancer
4
‘Relatively Low’ AEs Noted With Durvalumab/FLOT in Gastric/GEJ Cancer
5